Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Post by barry1981on Apr 13, 2011 2:53pm

375 Views

Post# 18426196

Going to be $4

BMO, NAT are coming up with big sell orders. BMO just a pul a sell of 100,000 shares at $4.46 followed by Natbank of 10,000 shares at arounf $4.50 $4.55 $4.66. No BUYING at all. Ouch... didnt see this coming. Hanging there with 8000 shares @5.01.

Bullboard Posts

98% energy efficiency: How Acceleware's EM Technology is transforming heat solutions